Pre-surgical triple therapy shows promise for treating non-small lung cancer
Researchers from the NEOSTAR Phase II trial reported that the addition of ipilimumab to a neoadjuvant (pre-surgical) combination of nivolumab plus platinum-based chemotherapy resulted in a major pathologic… read more.